Cyclodextrins in eye drop formulations:: enhanced topical delivery of corticosteroids to the eye

被引:144
|
作者
Loftsson, T
Stefánsson, E
机构
[1] Univ Iceland, Fac Pharm, Reykjavik, Iceland
[2] Univ Iceland, Fac Med, Reykjavik, Iceland
[3] Decode Genet Inc, Reykjavik, Iceland
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2002年 / 80卷 / 02期
关键词
drug delivery; eye drops; cyclodextrin; steroids; solubility;
D O I
10.1034/j.1600-0420.2002.800205.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Cyclodextrins are cylindrical oligosaccharides with a lipophilic central cavity and hydrophilic outer surface. They can form water-soluble complexes with lipophilic drugs, which 'hide' in the cavity. Cyclodextrins can be used to form aqueous eye drop solutions with lipophilic drugs, such as steroids and some carbonic anhydrase inhibitors. The cyclodextrins increase the water solubility of the drug, enhance drug absorption into the eye, improve aqueous stability and reduce local irritation. Cyclodextrins are useful excipients in eye drop formulations of various drugs, including steroids of any kind, carbonic anhydrase inhibitors, pilocarpine, cyclosporins, etc. Their use in ophthalmology has already begun and is likely to expand the selection of drugs available as eye drops. In this paper we review the properties of cyclodextrins and their application in eye drop formulations, of which their use in the formulation of dexamethasone eve drops is an example. Cyclodextrins have been used to formulate eve drops containing corticosteroids, such as dexamethasone, with levels of concentration and ocular absorption which, according to human and animal studies, are many times those seen with presently available formulations. Cyclodextrin-based dexamethasone eye drops are well tolerated in the eye and seem to provide a higher degree of bioavailability and clinical efficiency than the steroid eye drop formulations presently available. Such formulations offer the possibility of once per day application of corticosteroid eye drops after eye surgery, and more intensive topical steroid treatment in severe inflammation. While cyclodextrins have been known for more than a century, their use in ophthalmology is just starting. Cyclodextrins are useful excipients in eye drop formulations for a variety of lipophilic drugs. They will facilitate eye drop formulations for drugs that otherwise might not be available for topical use, while improving absorption and stability and decreasing local irritation.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [31] Topical Drug Delivery to the Posterior Segment of the Eye
    Loescher, Marina
    Seiz, Chiara
    Hurst, Jose
    Schnichels, Sven
    PHARMACEUTICS, 2022, 14 (01)
  • [32] A clinical study of the efficacy of topical corticosteroids on dry eye.
    Yang C.Q.
    Sun W.
    Gu Y.S.
    Journal of Zhejiang University SCIENCE B, 2006, 7 (8): : 675 - 678
  • [33] Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
    Martin-Sabroso, Cristina
    Alonso-Gonzalez, Mario
    Fernandez-Carballido, Ana
    Aparicio-Blanco, Juan
    Cordoba-Diaz, Damian
    Navarro-Garcia, Federico
    Cordoba-Diaz, Manuel
    Torres-Suarez, Ana I.
    PHARMACEUTICALS, 2022, 15 (01)
  • [34] Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations
    Lanier, Olivia L.
    Manfre, Miranda G.
    Bailey, Claire
    Liu, Zhen
    Sparks, Zachary
    Kulkarni, Sandesh
    Chauhan, Anuj
    AAPS PHARMSCITECH, 2021, 22 (03)
  • [35] Innovative Famciclovir Eye Drop Formulations for Herpes Zoster Infections
    Domenech-Monsell, Iris M.
    Alambiaga-Caravaca, Adrian M.
    Bernat-Just, Lucia
    Merino, Virginia
    Rodilla, Vicent
    Balaguer-Fernandez, Cristina
    Lopez-Castellano, Alicia
    CURRENT EYE RESEARCH, 2025,
  • [36] Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations
    Olivia L. Lanier
    Miranda G. Manfre
    Claire Bailey
    Zhen Liu
    Zachary Sparks
    Sandesh Kulkarni
    Anuj Chauhan
    AAPS PharmSciTech, 22
  • [37] Retention and retention of effect of topical formulations in dry eye subjects
    Paugh, Jerry R.
    Nguyen, Andrew Loc
    Huang, Pochi
    Hwang, Julie S.
    OPTOMETRY AND VISION SCIENCE, 2008, 85 (09) : 873 - 879
  • [38] Ocular Hypotensive Effect for the Topical Amlodipine 0.5% Eye Drop
    Jabur, Murtadha S.
    Manna, Mohammed J.
    Mohammed, Haider Raheem
    Baqir, Luma Saad
    Abdulamir, Haidar A.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 : 311 - 314
  • [39] Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis
    A Kheirkhah
    M K Zavareh
    F Farzbod
    M Mahbod
    M J Behrouz
    Eye, 2011, 25 : 872 - 880
  • [40] Topical drug administration perception with and without eye drop applicator
    Portes, Arlindo Jose Freire
    de Oliveira e Silva, Marina Gabriela
    Viana, Marcella
    Paredes, Angela Flores
    Rocha, Julia
    REVISTA BRASILEIRA DE OFTALMOLOGIA, 2011, 70 (04) : 224 - 229